Linda Gold

1 month ago | healio.com | Gabrielle Capaldo |Kristen Dowd |Linda Gold

Key takeaways: Adults and children previously treated with Vtama cream 1% went through a treatment-free period of approximately 80 days. During that period, all patients maintained mild disease. ORLANDO — Atopic dermatitis disease activity remained mild after patients treated with Vtama cream 1% achieved nearly 80 consecutive treatment-free days, according to a presentation at the American Academy of Dermatology Annual Meeting.

1 month ago | dermatologytimes.com | Kaitlyn Bader |Linda Gold

“The idea of a treatment-free period is such that with the studies that we looked at with tapinarof and atopic dermatitis, we found that if you get patients with atopic dermatitis to completely clear skin, there was a durable treatment-free period of time, which was 80 consecutive days.

1 month ago | jamanetwork.com | Neal Bhatia |James Del Rosso |Linda Gold

Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials Key PointsQuestion  What is the efficacy and safety of DFD-29, 40 mg, a low-dose oral minocycline hydrochloride formulation, in moderate to severe rosacea compared with doxycycline, 40 mg, and placebo?

1 month ago | hcplive.com | Tim Smith |Linda Gold |Arash Mostaghimi |Brett King |Raj Chovatiya

Author(s):,This summary, featuring 4 leading experts, provides an overview of what dermatologists may look forward to during the AAD 2025 Annual Meeting. As the American Academy of Dermatology (AAD) 2025 Annual Meeting is beginning this week, the HCPLive editorial team interviewed 4 leading experts in the field of dermatology to describe the elements of AAD to which they are most looking forward.

Nov 18, 2024 | hcplive.com | Mona Shahriari |Linda Gold |Susan Taylor

In this episode of The Medical Sisterhood, host Mona Shahriari, MD, speaks with Susan Taylor, MD, and Linda Stein Gold, MD, two leaders in dermatology, about mentorship, professional growth, and the realities of balancing personal and professional responsibilities as women in medicine. Taylor, a professor and vice chair for Diversity, Equity, and Inclusion at the Perelman School of Medicine, shares how her mentor inspired her to develop the subspecialty of skin of color dermatology.